The Society of Biomolecular Imaging and Informatics (SBI2) is an international community of leaders, scientists, and students promoting technological advancement, discovery, and education to quantitatively interrogate biological models to provide high context information at the cellular level.

In collaboration with the organizers of SBI2, the Editor of ASSAY and Drug Discovery Technologies will dedicate this special issue specifically to biomolecular imaging and informatics research featured at the 2018 SBI2 Annual Conference held at the Joseph B. Martin Conference Center at Harvard Medical School, Cambridge, MA, September 18 - 20, 2018. This issue will be published to coincide with the annual meeting and will be distributed to all meeting attendees.

We are seeking high-quality review articles and original articles, topical reviews, and perspectives on the following topics related to the influence of SBI2 Research:

- Image based HTS
- Phenotypic profiling in chemical biology and drug discovery
- High content analytics
- Innovations — 3D, co-cultures and stem cell systems

Manuscripts should be approximately 3,000 words in length with a 300-word maximum for abstracts. All additional information for submission can be found in our Instructions for Authors.

Advantages of publishing in ASSAY and Drug Development Technologies include:

- Fast and user-friendly electronic submission
- Rapid, high quality peer-review
- Maximum exposure: accessible in 170 countries worldwide
- Open Access options availabl
- Competitive author benefits program